Coala Life’s respiratory monitoring solution can be used to remotely monitor heart and record lung sounds of patients quarantined at home. Credit: Coala Life, Inc.

Swedish digital health company Coala Life has expanded the indication of its heart monitor for use in Covid-19 respiratory diagnostic exams.

The US Food and Drug Administration (FDA)-cleared Coala Heart Monitor can now be used to monitor heart and record lung sounds of the home quarantined patients in one minute. In addition, it enables physicians to remotely read the analysed data and view a patient’s electrocardiogram (ECG).

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

This wireless device can be activated from the patient’s homes, unlike other medical devices, which require hospital-based enrollment.

Coala Life founder and president Philip Siberg said: “The Coala device was developed and validated in Sweden based on over ten years of research. It truly enables telemedicine with the ability to monitor respiratory sounds and cardiac-related conditions in the safety of patient’s homes and help eliminate the need for patient office visits.”

Introduced in Scandinavia in 2017 for cardiac patients, Coala Heart Monitor has recently secured the US FDA approval.

The smartphone-powered device is integrated with a high-performance wireless stethoscope and a synchronous high-resolution 2-lead ECG. It enables real-time remote diagnostics of arrhythmias, forms of congenital heart disease and certain respiratory disorders in patients.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Following FDA’s new enforcement policy to support patient monitoring during the Covid-19 pandemic, Coala’s respiratory monitoring solution will be available for purchase by prescription for existing and new users in the US and selected EU markets.

The company said that devices like the Coala Heart Monitor are in high demand in Europe due to the fast-spreading Covid-19 outbreak.

It allows home-based management of high-risk patients with coronary and pulmonary diseases.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact